Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products in the United States and internationally. The company offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers working in intensive care units; and Aerobika, an oscillating positive expiratory pressure device. The company offers its products for patients with chronic lung issues, including bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.
Industry, Sector and Symbol
Stock Exchange NYSEAMERICAN
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
SymbolNYSEAMERICAN:ELMD
CUSIPN/A
Phone+1-952-7589299
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins7.29%
Return on Equity10.39%
Return on Assets8.71%
Miscellaneous
EmployeesN/A
Outstanding Shares8,290,000
Market Cap$46.01 million
Electromed (NYSEAMERICAN:ELMD) Frequently Asked Questions
What is Electromed's stock symbol?
Electromed trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ELMD."
How were Electromed's earnings last quarter?
Electromed, Inc. (NYSEAMERICAN:ELMD) announced its quarterly earnings data on Tuesday, May, 8th. The medical equipment provider reported $0.04 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.07 by $0.03. The medical equipment provider had revenue of $7.09 million for the quarter. Electromed had a net margin of 7.29% and a return on equity of 10.39%. View Electromed's Earnings History.
When is Electromed's next earnings date?
Who are some of Electromed's key competitors?
Some companies that are related to Electromed include REVA Medical (RVA), Medica Group (MGP), Ellex Medical Lasers (ELXMF), Creo Medical Group (CREO), Hamilton Thorne (HTL), Kromek Group (KMK), Universal Biosensors (UBI), Advanced Oncotherapy (AVO), Protech Home Medical (PHM), MRI Interventions (MRIC), Surgical Innovations Group (SUN), Neuroone Medical Technologies (NMTC), PetVivo (PETV), Avacta Group (AVCT) and Myomo (MYO).
Who are Electromed's key executives?
Electromed's management team includes the folowing people:
- Ms. Kathleen S. Skarvan, CEO, Pres & Director (Age 62)
- Mr. Jeremy T. Brock CPA, CFO, Principal Accounting Officer & Financial Controller (Age 39)
- Mr. John Kowalczyk, VP of Sales & Marketing
- Mr. William J. George J.D., Sec. (Age 69)
- Ms. Kathryn Thompson, VP of Reimbursement
Has Electromed been receiving favorable news coverage?
News coverage about ELMD stock has been trending positive this week, Accern Sentiment Analysis reports. The research group identifies negative and positive media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Electromed earned a media and rumor sentiment score of 0.41 on Accern's scale. They also assigned media coverage about the medical equipment provider an impact score of 47.78 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future. View Recent Headlines for Electromed.
Who are Electromed's major shareholders?
Electromed's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Algert Global LLC (2.26%), Teton Advisors Inc. (1.35%), Gabelli Funds LLC (0.67%) and Renaissance Technologies LLC (0.50%). Company insiders that own Electromed stock include Red Oak Partners, Llc, Stan K Erickson, Stephen H Craney and William Eckles. View Institutional Ownership Trends for Electromed.
Which major investors are selling Electromed stock?
Which major investors are buying Electromed stock?
ELMD stock was bought by a variety of institutional investors in the last quarter, including Gabelli Funds LLC, Teton Advisors Inc. and Renaissance Technologies LLC. Company insiders that have bought Electromed stock in the last two years include Stan K Erickson, Stephen H Craney and William Eckles. View Insider Buying and Selling for Electromed.
How do I buy shares of Electromed?
Shares of ELMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Electromed's stock price today?
One share of ELMD stock can currently be purchased for approximately $5.27.
How big of a company is Electromed?
Electromed has a market capitalization of $46.01 million.
How can I contact Electromed?
Electromed's mailing address is 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States. The medical equipment provider can be reached via phone at +1-952-7589299.
MarketBeat Community Rating for Electromed (NYSEAMERICAN ELMD)
MarketBeat's community ratings are surveys of what our community members think about Electromed and other stocks. Vote "Outperform" if you believe ELMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ELMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
